Pulmatrix Inc. Stock
Price
Target price
€1.64
€1.64
-1.200%
-0.02
-1.200%
€9.15
09.05.24 / Stuttgart Stock Exchange
WKN: A3DWEE / Symbol: PULM / Name: Pulmatrix / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pulmatrix Inc. Stock
We can see a decrease in the price for Pulmatrix Inc.. Compared to yesterday it has lost -€0.020 (-1.200%).
With 1 Sell predictions and 1 Buy predictions the community sentiment towards the Pulmatrix Inc. stock is not clear.
With a target price of 9 € there is potential for a 448.78% increase which would mean more than doubling the current price of 1.64 € for Pulmatrix Inc..
So far the community has only identified positive things for Pulmatrix Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Pulmatrix Inc. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Pulmatrix Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Pulmatrix Inc. | -1.200% | -2.381% | 0.000% | -34.661% | 0.122% | -88.201% | -91.100% |
| Ardelyx Inc. | -3.860% | -10.646% | 8.770% | 81.814% | 24.879% | 33.667% | - |
| Evolus Inc | -1.650% | -3.252% | 1.709% | 39.181% | 31.492% | 59.732% | - |
| Salarius Pharmaceuticals Inc. | 2.480% | -8.811% | 2.985% | -70.216% | -25.405% | -98.392% | -99.993% |
Comments
Pulmatrix, Inc. (NASDAQ: PULM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Show more
Ratings data for PULM provided by MarketBeat
